Umedica Company Profile
✉ Email this page to a colleague
What is the competitive landscape for UMEDICA, and what generic and branded alternatives to UMEDICA drugs are available?
UMEDICA has fifteen approved drugs.
Summary for Umedica
| US Patents: | 0 |
| Tradenames: | 14 |
| Ingredients: | 14 |
| NDAs: | 15 |
Drugs and US Patents for Umedica
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Umedica | CARBAMAZEPINE | carbamazepine | TABLET, EXTENDED RELEASE;ORAL | 216594-001 | Aug 18, 2022 | AB | RX | No | No | ⤷ Sign Up | ⤷ Sign Up | ||||
| Umedica | EFINACONAZOLE | efinaconazole | SOLUTION;TOPICAL | 211969-001 | Jun 21, 2021 | AB | RX | No | No | ⤷ Sign Up | ⤷ Sign Up | ||||
| Umedica | SUCCINYLCHOLINE CHLORIDE | succinylcholine chloride | INJECTABLE;INJECTION | 211625-001 | May 19, 2020 | AP | RX | No | No | ⤷ Sign Up | ⤷ Sign Up | ||||
| Umedica | NEOSTIGMINE METHYLSULFATE | neostigmine methylsulfate | SOLUTION;INTRAVENOUS | 212627-002 | Nov 3, 2022 | AP | RX | No | No | ⤷ Sign Up | ⤷ Sign Up | ||||
| Umedica | CELECOXIB | celecoxib | CAPSULE;ORAL | 210628-002 | Nov 27, 2019 | AB | RX | No | No | ⤷ Sign Up | ⤷ Sign Up | ||||
| Umedica | CHLORTHALIDONE | chlorthalidone | TABLET;ORAL | 207222-001 | May 24, 2018 | AB | RX | No | No | ⤷ Sign Up | ⤷ Sign Up | ||||
| Umedica | OLMESARTAN MEDOXOMIL | olmesartan medoxomil | TABLET;ORAL | 207135-001 | Jul 18, 2019 | AB | RX | No | No | ⤷ Sign Up | ⤷ Sign Up | ||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
Similar Applicant Names
Applicants may be listed under multiple names.
Here is a list of applicants with similar names.
Here is a list of applicants with similar names.
